T. ULUS Et Al. , "The effect of spironolactone on atrial conduction in patients with heart failure with reduced ejection fraction," 34. ULUSLARARASI KATILIMLI TÜRK KARDİYOLOJİ KONGRESİ , vol.20, Antalya, Turkey, pp.111, 2018
ULUS, T. Et Al. 2018. The effect of spironolactone on atrial conduction in patients with heart failure with reduced ejection fraction. 34. ULUSLARARASI KATILIMLI TÜRK KARDİYOLOJİ KONGRESİ , (Antalya, Turkey), 111.
ULUS, T., MOGHANCHIZADEH, S. H., DURAL, M., MERT, K. U., BİLGİN, M., & MUTLU, F., (2018). The effect of spironolactone on atrial conduction in patients with heart failure with reduced ejection fraction . 34. ULUSLARARASI KATILIMLI TÜRK KARDİYOLOJİ KONGRESİ (pp.111). Antalya, Turkey
ULUS, TANER Et Al. "The effect of spironolactone on atrial conduction in patients with heart failure with reduced ejection fraction," 34. ULUSLARARASI KATILIMLI TÜRK KARDİYOLOJİ KONGRESİ, Antalya, Turkey, 2018
ULUS, TANER Et Al. "The effect of spironolactone on atrial conduction in patients with heart failure with reduced ejection fraction." 34. ULUSLARARASI KATILIMLI TÜRK KARDİYOLOJİ KONGRESİ , Antalya, Turkey, pp.111, 2018
ULUS, T. Et Al. (2018) . "The effect of spironolactone on atrial conduction in patients with heart failure with reduced ejection fraction." 34. ULUSLARARASI KATILIMLI TÜRK KARDİYOLOJİ KONGRESİ , Antalya, Turkey, p.111.
@conferencepaper{conferencepaper, author={TANER ULUS Et Al. }, title={The effect of spironolactone on atrial conduction in patients with heart failure with reduced ejection fraction}, congress name={34. ULUSLARARASI KATILIMLI TÜRK KARDİYOLOJİ KONGRESİ}, city={Antalya}, country={Turkey}, year={2018}, pages={111} }